Shandong Luba Chemical Co.,Ltd
Beijing Multigrass Formulation Co., Ltd.

Frontage Laboratories acquires Concord Biosciencesqrcode

Favorites Print Apr. 13, 2018
Frontage Laboratories Inc.
Follow
Concord Biosciences LLC
Follow
Frontage Laboratories Inc., a global CRO with headquarters in Exton, Pennsylvania, announces the acquisition of Concord Biosciences, formerly known as Ricerca Biosciences LLC, a preclinical CRO located near Cleveland, Ohio. Founded in 1986, Concord Bio supports the pharmaceutical, agricultural, chemical and animal health industries with Drug Safety, Metabolism, Bioanalytical, Residue and Environmental Fate studies.
 
Dr. Song Li, founder and CEO of Frontage Laboratories, said, "We have committed to build a global CRO company with integrated services. The acquisition of Concord Biosciences is a significant step toward reaching our goal. The addition of Concord Bio to the Frontage family will enable us to provide pharmaceutical product development services from lead selection to IND-enabling studies to commercialization. Additionally, the agrochemical expertise of Concord Bio will position Frontage as a major CRO in the agricultural products industry."
 
Favorites Print
Source: PRNewswire

0/1200

More from AgroNews

Magazine

  • 2018 Biologicals Special 2010 India Pesticide Suppliers Guide
  • 2017 Chinese issue of Biologicals Special Chinese issue of Annual Review 2017
  • 2018 India Pesticide Suppliers Guide 2018 Formulation & Adjuvant Technology

Subscribe to daily email alerts of AgroNews.